Amgen實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

最新新聞

Space.Xia 2025 Apr 23, 16:00

黃金價格劇烈震盪,牛市是否即將觸頂?

Frances Wang 2025 Apr 22, 16:00

歐洲央行會降息嗎?利率如何影響債券市場?

Frances Wang 2025 Apr 22, 16:00

關稅新聞:亞洲市場上漲,日元因關稅談判下跌

Frances Wang 2025 Apr 22, 16:00

今日AMD股價:影響AMD股價的因素

Frances Wang 2025 Apr 21, 16:00

今日股市:道瓊斯、標普500和納斯達克因特朗普批評聯邦儲備主席鮑威爾而下跌

Frances Wang 2025 Apr 21, 16:00

亞洲股市指數:恆生指數下跌,日經225指數下滑,印度Sensex上漲

Frances Wang 2025 Apr 21, 16:00

今日金價:XAUUSD超過3,400美元,面對關稅不確定性

Frances Wang 2025 Apr 21, 16:00

今日外匯市場:美元跌至三年低點,USD/CHF接近0.8102

聯絡方式

點差

1.91

點差(%)

0.6846 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期五

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

149681930240

流通股份

537204992

收益日期(下一個)

1999-11-22

現金殖利率 

2025-06-06

除息日

2025-05-16

遠期年股息率

9.52

遠期年現金殖利率

0.0343

每股盈餘

7.56

了解有關此金融工具的詳細資訊

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具
Trustpilot